Jade
Jade Diabetes is a Melbourne-based software company whose mobile app provides AI-driven insulin dose calculations, multi-hour blood-glucose predictions, and personalized coaching for people with insulin-dependent diabetes, integrating with CGMs, food, fitness and health-tracking apps.
- Company typePrivate
- Founded2012
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Jade does
Jade Diabetes Pty Ltd (operating as Jade, formerly PredictBGL and ManageBGL) is a privately held Melbourne-based software company founded in 2012 by the founders of DataMystic. It develops a smartphone insulin-dosing application for people with insulin-dependent diabetes (Type 1, Type 1.5/LADA, Type 2, and Gestational), powered by a proprietary AI blood-glucose prediction engine adapted from closed-loop artificial pancreas algorithms and applied to multiple daily injection therapy. The core product tracks 64 types of diabetes data, integrates with Dexcom and Abbott FreeStyle Libre continuous glucose monitors, NightScout, connected glucometers (including iHealth), food databases (5 million items via MyFitnessPal, CalorieKing, FatSecret), fitness devices, period and pain trackers, and digital insulin pens, while offering personalized coaching, gamification, hypo/hyper alerts, and a Tele Health workflow.
The platform extends beyond the consumer app into CamperView Remote Patient Monitoring for endocrinologists, diabetes educators, and schools, an Amazon Alexa voice skill, an Open API supporting 60+ diabetic devices and legacy systems, and a web portal for healthcare professional research and triage. The app achieved Class 1 Medical Device regulation by FDA/TGA in August 2023, with data hosted on AWS infrastructure aligned to HIPAA, SOC 1/2/3, PCI DSS Level 1, ISO 27001, FedRAMP, FISMA, and ITAR standards.
Jade operates a freemium-to-subscription model: a free trial converts into recurring subscription revenue from individuals, with emerging coverage from healthcare providers who prescribe the app and payers/insurers who cover it for eligible patients. Go-to-market is primarily product-led via Apple App Store and Google Play self-serve downloads, supplemented by healthcare-provider referrals, content marketing, social media, and email. The platform reports a user base of 25,000-43,000+ people with diabetes globally, with only one disclosed institutional capital event (a 2020 500 Global investment) and a headcount in the 11-50 range.
Jade firmographics
Firmographics- Name
- Jade
- Legal name
- Jade Diabetes Pty Ltd
- Website
- https://jadediabetes.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Jade Diabetes is a Melbourne-based software company whose mobile app provides AI-driven insulin dose calculations, multi-hour blood-glucose predictions, and personalized coaching for people with insulin-dependent diabetes, integrating with CGMs, food, fitness and health-tracking apps.
- Ownership category
- akta.pro rank
Jade industry classification
Industry- Product category
- Diabetes Management Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)
- akta.pro secondary industries
- Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where Jade is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Jade business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- App Subscription (Freemium with Free Trial): The service offers a FREE trial period, followed by subscription-based access to the full Jade Diabetes app with premium features including advanced dose calculations, predictions, coaching, and unlimited device sync. The company generates recurring subscription revenue from individuals, healthcare providers, and payers (insurance companies) who cover the app for patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Trial Period |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Jade product offering
Product offeringCore offering
Jade Diabetes provides a smartphone insulin dosing app that calculates insulin doses, predicts blood glucose levels hours ahead (with 87% accuracy up to three hours ahead), and offers coaching for people with insulin-dependent diabetes (Type 1, LADA/Type 1.5, Type 2, Gestational). It integrates live data from continuous glucose monitors (Dexcom, FreeStyle Libre, NightScout), connected glucometers, food apps covering 5 million foods, fitness devices, digital insulin pens, period trackers, and pain trackers. The platform uses the same algorithms as closed-loop artificial pancreas systems but applies them to multiple daily injection therapy, with companion modules for healthcare provider remote patient monitoring (CamperView), Alexa voice control, telehealth, an open developer API, and a points-based gamification system.
Product overview
Jade Diabetes is a unified diabetes management platform centered on a smartphone insulin dosing app (formerly PredictBGL and ManageBGL) that provides dose calculations and blood glucose predictions using closed-loop artificial pancreas algorithms applied to multiple daily injection therapy. The platform operates as a single product with integrated modules including CamperView (Remote Patient Monitoring), an Alexa voice skill, Tele Health consultation support, an Open API for device integrations, a Points System for gamification, and iHealth device connectivity. Available for both iOS and Android smartphones and tablets with live data sync between unlimited devices.
Differentiator
Problem solved
Functional benefit
Brands
- Jade: Main diabetes management app brand providing insulin dosing calculations, blood glucose predictions, and coaching for people with Type 1, Type 1.5, Type 2, Gestational, and LADA diabetes
Products and services
- Jade Diabetes App Smartphone insulin dosing app (iOS and Android) for people with insulin-dependent diabetes (Type 1, Type 1.5/LADA, Type 2, Gestational). Provides dose calculations using insulin-on-board tracking, AI-powered blood glucose predictions up to three hours ahead, hypo/hyper alerts, food logging across 5 million foods, coaching with gamification, and live integration with Dexcom, FreeStyle Libre, NightScout, connected glucometers, fitness devices, digital insulin pens, period trackers, and pain trackers via Apple HealthKit.
- CamperView Remote Patient Monitoring Enterprise remote patient monitoring module that lets healthcare providers, clinics, schools, and camp staff view patient diabetes data live. Supports in-patient, clinic, and school camp care with extensive reporting, population-level statistics, and patient triage capabilities. Targets endocrinologists, diabetes educators, school nurses, and clinicians running diabetes camps.
- Jade Diabetes Portal Web portal that supports remote patient monitoring and clinical research by healthcare professionals, with extensive reporting, population statistics, and patient triage capabilities. Companion to the mobile app for clinical use cases.
- Jade API Open developer API that enables import from over 60 diabetic devices and legacy diabetes management systems, and allows developers to build vendor applications integrating mobile health apps and devices. Supports remote patient monitoring and clinical research use cases.
Quantifiable outcome
- 87% accurate blood glucose predictions up to three hours ahead
- +2 more outcomes
Companies that use Jade
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
Jade technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration15 records
AI capability2 records
Feature5 records
Jade partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and supporting.
- DexcomcoreDexcom CGM integration allowing live blood glucose data streaming into Jade Diabetes. Supports Dexcom G7, G6, G5, G4 with Share. Five-minute blood sugar data is seamlessly integrated for dosing calculations and predictions.
- Abbott (FreeStyle Libre)coreFreeStyle Libre CGM integration with support for FreeStyle Libre, FreeStyle Libre 2 using LibreLink. Data seamlessly integrated into the Jade platform for continuous monitoring.
- NightScoutcoreNightScout open-source artificial pancreas system integration. Data from the NightScout system is accepted to allow integration with APS (Open Source Artificial Pancreas).
- Apple HealthcoreApple Health integration allowing point-in-time data from connected glucometers, fitness devices, food apps, and insulin data sources via HealthKit on iPhone.
- Amazon AlexacoreAmazon Alexa voice assistant integration allowing users to manage diabetes with voice commands through the Jade Alexa skill.
- MyFitnessPalsupportingFood app integration for precise carbohydrate, protein, fat and fiber data from 5 million foods for accurate dose calculations.
- CalorieKingsupportingFood database integration for carbohydrate counting and nutrition data from CalorieKing food database.
- FatSecretsupportingFood app integration providing nutrition data integration for meal logging and dose calculations.
- iHealth (iBG5s)supportingiHealth iBG5s Bluetooth blood glucose meter integration for wireless data sync with Jade Diabetes app.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Jade competitors and assessment
Company assessmentDirect peers
- One Drop: Subscription-based diabetes management app with coaching, CGM data integration, and a direct-to-consumer hardware glucometer offering. Competes with Jade for self-pay T1D/T2 insulin users willing to pay for premium features.
- Glooko: Diabetes data management platform that aggregates data from 95+ devices and serves both consumers and healthcare providers via Mobile Insulin Dosing System (MIDS). Comparable in its multi-device integration strategy and healthcare-provider RPM focus.
- DarioHealth: Chronic condition management platform with a diabetes-focused product line including connected glucometer hardware, app-based coaching, and B2B payer contracts. Comparable in its subscription-plus-coaching model and employer/payer go-to-market.
- Tidepool: Nonprofit diabetes data platform supporting multiple pumps and CGMs with clinician-facing analytics. Comparable integration breadth and provider focus, though positioned as a data platform rather than a consumer dose calculator.
- Sugarmate: Tandem Diabetes Care-owned CGM companion app providing visualization, alerts, and Siri/Tidepool integration. Competes directly with Jade's CGM-data interpretation layer, though lacks Jade's predictive AI bolus engine.
- mySugr: Diabetes management app offering logging, bolus estimation, and coaching. Acquired by Roche in 2017, it is the most direct competitor in the consumer diabetes dose-tracking space and overlaps heavily with Jade's MDI user base.
- Diabetes:M: Mobile diabetes management app offering logging, bolus calculation, and reports on iOS/Android. Smaller scale direct peer in the consumer dose-tracking category with comparable freemium model.
Broad incumbents
- Dexcom: Largest CGM manufacturer with companion apps (Dexcom Clarity, Follow app) that increasingly add dose guidance. As Jade's primary data source, Dexcom is both partner and a potential competitive threat should it extend prediction features natively.
- Insulet (Omnipod): Leading tubeless insulin pump maker whose Omnipod 5 AID system includes SmartBolus calculator and trend-based dose adjustments. Represents the closed-loop alternative to Jade's MDI positioning and the most direct premium substitute for users who can afford pump therapy.
- Abbott (FreeStyle Libre): Second-largest CGM manufacturer whose LibreLink app provides glucose data visualization and trend analysis. Similar competitive overlap as Dexcom; LibreLinkUp family app targets the same caregiver use case as Jade's parent-monitoring features.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Jade social profiles
Digital presenceJade compliance and trust
Trust signalCompliance13 records
Jade financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jade leadership team
Management profileNumber of profiles
Profiles1 record
Jade funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jade M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jade
What does Jade do?
Jade Diabetes provides a smartphone insulin dosing app that calculates insulin doses, predicts blood glucose levels hours ahead (with 87% accuracy up to three hours ahead), and offers coaching for people with insulin-dependent diabetes (Type 1, LADA/Type 1.5, Type 2, Gestational). It integrates live data from continuous glucose monitors (Dexcom, FreeStyle Libre, NightScout), connected glucometers, food apps covering 5 million foods, fitness devices, digital insulin pens, period trackers, and pain trackers. The platform uses the same algorithms as closed-loop artificial pancreas systems but applies them to multiple daily injection therapy, with companion modules for healthcare provider remote patient monitoring (CamperView), Alexa voice control, telehealth, an open developer API, and a points-based gamification system.
Is Jade a public or private company?
Jade is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Jade founded?
Jade was founded in 2012. It employs 11 to 50 people.
Where is Jade based?
Jade is headquartered in Melbourne, Australia, in the Oceania region.
How does Jade make money?
One revenue line is on record: app Subscription (Freemium with Free Trial).
Who are Jade's main competitors?
Direct peers on record are One Drop, Glooko, DarioHealth, Tidepool, Sugarmate, mySugr and Diabetes:M. Broad incumbents are Dexcom, Insulet (Omnipod) and Abbott (FreeStyle Libre).
Does Jade have an API?
Yes. Jade provides an Open API that allows import capability from over 60 diabetic devices, legacy diabetes management systems, and allows developers to create vendor applications for integrating mobile health apps and devices. The API supports remote patient monitoring and research by Health Care Professionals. Developer documentation is at www.jadediabetes.com/api.
What industry is Jade in?
Jade's product category is Diabetes Management Software. Its primary akta.pro industry code is HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators), with a secondary code of HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms. Its NAICS code is 5182 and its SIC code is 2835.